dc.contributor.author | Løvik, Martinus | |
dc.contributor.author | Frøyland, Livar | |
dc.contributor.author | Haugen, Margaretha | |
dc.contributor.author | Henjum, Sigrun | |
dc.contributor.author | Holvik, Kristin | |
dc.contributor.author | Skålhegg, Bjørn Steen | |
dc.contributor.author | Stea, Tonje Holte | |
dc.contributor.author | Strand, Tor A | |
dc.contributor.author | Iversen, Per Ole | |
dc.date.accessioned | 2018-03-08T17:07:20Z | |
dc.date.available | 2018-03-08T17:07:20Z | |
dc.date.created | 2017-10-13T13:33:29Z | |
dc.date.issued | 2017 | |
dc.identifier.isbn | 978-82-8259-267-3 | |
dc.identifier.uri | http://hdl.handle.net/11250/2489598 | |
dc.description.abstract | At the request of the Norwegian Food Safety Authority, the Norwegian Scientific Committee for Food Safety (VKM) has characterised the risk of specified doses of L-threonine in food supplements. VKM concludes that: In adults (≥18 years), the specified doses 1000, 1200, 1500, 2000 and 2400 mg/day L-threonine in food supplements are unlikely to cause adverse health effects. In adolescents (14 to <18 years), the specified doses 1000, 1200, 1500, 2000 and 2400 mg/day L-threonine in food supplements are unlikely to cause adverse health effects. In children (10 to <14 years), the specified doses 1000, 1200, 1500, 2000 and 2400 mg/day L-threonine in food supplements are unlikely to cause adverse health effects. | nb_NO |
dc.language.iso | eng | nb_NO |
dc.publisher | Norwegian Scientific Committee for Food Safety (VKM) | nb_NO |
dc.relation.ispartof | VKM Report | |
dc.relation.ispartofseries | VKM Report;2017: 10 | |
dc.relation.uri | https://vkm.no/risikovurderinger/allevurderinger/andrestoffer/ltreoninikosttilskudd.4.761cd04215dabef8a9e83ca6.html | |
dc.title | Risk assessment of "other substances" – L-threonine. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safety | nb_NO |
dc.type | Research report | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.source.pagenumber | 39 | nb_NO |
dc.source.issue | 2017:10 | nb_NO |
dc.identifier.cristin | 1504466 | |
cristin.unitcode | 194,65,15,0 | |
cristin.unitname | Institutt for klinisk og molekylær medisin | |
cristin.ispublished | true | |
cristin.fulltext | original | |